Loading market dashboard
Novavax, Inc.
NVAXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Novavax, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $464.87M | $294.89M - $658.82M | -$183.56M | $0.803 | 3 |
| Dec 2029 | $430.99M | $273.40M - $610.81M | -$170.19M | $0.784 | 5 |
| Dec 2028 | $361.66M | $361.66M - $361.66M | -$142.81M | $0.487 | 6 |
| Dec 2027 | $258.47M | $140.61M - $371.71M | -$102.06M | -$0.254 | 7 |
| Dec 2026 | $409.97M | $308.49M - $495.77M | -$161.89M | -$0.472 | 7 |
| Dec 2025 | $1.06B | $675.17M - $1.07B | -$420.28M | $2.234 | 6 |
| Dec 2024 | $684.94M | $681.74M - $688.13M | -$270.46M | -$1.325 | 4 |
| Dec 2023 | $987.67M | $626.53M - $1.40B | -$390.00M | -$2.282 | 3 |
| Dec 2022 | $2.01B | $1.75B - $2.91B | -$4.93B | -$7.164 | 1 |
| Dec 2021 | $1.26B | $1.10B - $1.83B | -$3.89B | -$13.702 | 2 |
| Dec 2020 | $446.35M | $389.36M - $647.15M | -$304.64M | -$5.807 | 2 |
| Dec 2019 | $11.90M | $10.38M - $17.26M | -$8.12M | -$5.436 | 1 |